Featured Press Releases
IPO
-
Balqon BLQN(OTC.BB) Contract from the Port of Los Angeles to Retrofit Electric Yard Tractors
Contract funding of $630,000 to retrofit existing yard tractors with Balqon's Lithium Battery System /EINPresswire.com/HARBOR CITY, California. May 16, 2012—Balqon Corporation (OTCBB: BLQN), a developer of electric vehicles, drive systems...
-
Balqon BLQN(OTC.BB) Contract from the Port of Los Angeles to Retrofit Electric Yard Tractors
Contract funding of $630,000 to retrofit existing yard tractors with Balqon's Lithium Battery System /EINPresswire.com/HARBOR CITY, California. May 16, 2012—Balqon Corporation (OTCBB: BLQN), a developer of electric vehicles, drive systems...
-
GUIDING LIGHT: How MGLT (OTC.BB) is Revolutionizing Solar Power
GUIDING LIGHT: How MGLT (OTC.BB) is Revolutionizing Solar Power MGLT (OTC.BB) Current Price .06 /EINPresswire.com/For a decade now, businesses and politicians around the globe have gone "green" and molded their campaigns around the environment....
-
Amarantus BioSciences to Present at the Wall Street 1-2-1 Conference AMBS(OTC.BB)
/EINPresswire.com/ SUNNYVALE, CA- May 9, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF) for the treatment of Parkinson's disease and other nervous...
-
Balqon's Battery Storage System Powers Up Building. BLQN (OTC.BB)
Balqon Corporation (BLQN.OB) Balqon Corporation's 1 Mega Watt Hour Battery Storage System Went Live on May 5th, 2012 - Powering the Bourns College of Engineering Building at the University of California, Riverside /EINPresswire.com/ HARBOR...
-
Adviatech Closes Strongest Fiscal Year in Company History
Online marketing company, Adviatech Corp., closes its strongest fiscal year in the company's history. The 2011 tax year is Adviatech's eighth fiscal year. /EINPresswire.com/Tampa, FL - The company that owns popular law firm marketing brands...
-
EastBridge Investment Group, A Value Play On The OTC.BB
/EINPresswire.com/ EastBridge Investment Group Update: (EBIG .OTC.BB) Avg vol : 121,528 , p/e 14 , 52 week range .04-.12 A 6-CENT STOCK THAT PAYS A DIVIDEND Business Model: EastBridge ( EBIG.BB) currently held by more...
-
Amarantus BioSciences' AMBS.BB CEO on the Big Biz Radio Show
/EINPresswire.com/ SUNNYVALE, CA - March 19, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced the company will be a featured guest...
-
Amarantus BioSciences' CEO Scheduled to Appear on The Big Biz Radio Show
Amarantus BioSciences' CEO Gerald Commissiong Scheduled to Appear on The Big Biz Radio Show /EINPresswire.com/ SUNNYVALE, CA - January 12, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class...
-
Amarantus BioSciences Interview at the 2012 Biotech Showcase
/EINPresswire.com/ SUNNYVALE, CA - January 20, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, was interviewed at the 2012 Biotech Showcase in...
-
Amarantus BioSciences to be Interviewed on The Big Biz Radio Show
/EINPresswire.com/SUNNYVALE, CA - January 12, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced the company will be a featured guest...
-
Amarantus BioSciences Releases New Video Interview with President and CEO Gerald Commissiong
/EINPresswire.com/ Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Recently, the biotech company released...
-
Amarantus BioSciences Updates Shareholders on Execution of Expanded Corporate Strategy
/EINPresswire.com/ SUNNYVALE, Calif. Amarantus BioSciences, Inc. (OTCBB: AMBS.OB - News), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today provided shareholders with an update on the execution...
-
Amarantus BioSciences to Present (NIBA) 120th Investment Conference
IR Sense Remy Barnarda Remy@irsense.com 415.203.6386 Amarantus BioSciences to Present at the National Investment Banking Association's (NIBA) 120th Investment Conference /EINPresswire.com/ SUNNYVALE, CA- December 1, 2011 - Amarantus...
-
Webcast Interview (OTCBB: AMBS) Amarantus BioSciences, Inc
New Webcast Interview with President and CEO Gerald Commissiong (OTCBB: AMBS) Now Available at TheGreenBaron.com; The Green Baron Report Makes AMBS New "Stock Pick" /EINPresswire.com/ SUNNYVALE, CA - November 29, 2011 - Amarantus BioSciences,...
Follow us
What people say
Our Partners
© 2005-2012